The coronavirus disease 2019 (COVID-19) pandemic has created a public health crisis. This study aimed to evaluate the diagnostic performance of the Panbio and STANDARD Q COVID-19 antigen rapid ...
ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the ...
Abbott has been using its rapid antigen tests since last October to help clear its own employees through a phased rollout across its global workforce. (Abbott) () Abbott has received new COVID-19 ...
The Panbio self-test, which returns nasal swab results in about 15 minutes, was previously cleared in Germany and France for national coronavirus testing programs in schools and workplaces. (Abbott) ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results